In the last part of November 2025, Eli Lilly and Company NYSE: LLY shattered a historic ceiling. The Indianapolis-based drugmaker became the first pharmaceutical company to reach a market capitalizati
Advisors Asset Management Inc. trimmed its stake in shares of Eli Lilly and Company (NYSE: LLY) by 7.7% in the second quarter, according to the company in its most recent filing with the SEC. The firm
Guru Stock PicksElfun Trusts has made the following transactions:Reduce in MLM by 7.18%Sold out in KVUEAdd in TXN by 36.84%New position in AMDStock News Tech-le
Updated results from the Phase 3 EMBER-3 trial for Inluriyo™ (imlunestrant) alone and in combination with Verzenio® (abemaciclib) in ER+, HER2– metastatic breast cancer to be presented as a late-
Evan Seigerman, BMO head of health care research, joins 'The Exchange' to discuss the gap between Novo Nordisk and Eli Lilly, the valuation gap between the stocks and much more.
Exploring Elfun Trusts (Trades, Portfolio)' Strategic Moves in Q3 2025 Elfun Trusts (Trades, Portfolio) recently submitted its N-PORT filing for the third quar
Results from the BRUIN CLL-314 study comparing Jaypirca (pirtobrutinib) to Imbruvica (ibrutinib) – the first-ever head-to-head Phase 3 study versus a covalent BTK inhibitor to include treatment-naï
Stock News Wall Street steadies; AI and pharma in focus: U.S. stocks rebounded Friday but closed the week lower as rate-cut odds rose after New York Fed Preside
Burk Holdings LLC bought a new stake in Eli Lilly and Company (NYSE: LLY) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 582 shares of
Alphabet's dividend is still new but looks secure given its fantastic business and growth prospects. Eli Lilly is increasing its top line at a dizzying pace and has a strong dividend growth record ove
Barings LLC increased its position in Eli Lilly and Company (NYSE: LLY) by 4.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The insti
Bank Julius Baer and Co. Ltd Zurich reduced its holdings in Eli Lilly and Company (NYSE: LLY) by 8.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange
Eli Lilly stock has risen 36% this year to reach a $1 trillion market capitalization – the first health-care company to reach this milestone, according to CNBC.
Eli Lilly has surged 47% since my last article, exceeding my previous $800 price target and reaching all-time highs near $1,030. LLY's leadership in the obesity treatment market continues to drive top
Bahl and Gaynor Inc. trimmed its stake in Eli Lilly and Company (NYSE: LLY) by 1.5% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commis
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE